Healia Diagnostics Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 05-07-2024
- Company Age 6 years 8 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.00 Cr
as on 05-07-2024
- Revenue 11953.44%
FY 2023
- Profit -679144.19%
FY 2023
- Ebitda -24272.11%
FY 2023
- Net Worth -10145.87%
FY 2023
- Total Assets 950.37%
FY 2023
About Healia Diagnostics
The Corporate was formerly known as Ishaanvi Health Care Systems Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The Corporate currently has active open charges totaling ₹11.00 Cr.
Rajkumar Anirudh, Chitrakala Rajkumar, and Janavikulam Rajkumar serve as directors at the Company.
- CIN/LLPIN
U74999TN2018PTC120373
- Company No.
120373
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2018
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Healia Diagnostics?
Board Members(3)
Financial Performance and Corporate Structure Insights of Healia Diagnostics.
Healia Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11953.44% increase. The company also saw a substantial fall in profitability, with a 679144.19% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10145.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healia Diagnostics?
In 2023, Healia Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lifeline Multi Speciality Hospitals Private Limited
Active
27 years 7 months Rajkumar Anirudh, Chitrakala Rajkumar and 1 more are mutual person
Hdgtl India Private Limited
Active 8 years 9 months Chitrakala Rajkumar and Janavikulam Rajkumar are mutual person
Om Sai Medical Education Private Limited
Active 12 years 4 months Janavikulam Rajkumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Aug 2022 | ₹11.00 Cr | Open |
How Many Employees Work at Healia Diagnostics?
Healia Diagnostics has a workforce of 52 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jan 31, 2023, Healia Diagnostics has raised a total of ₹ 9.9 M, with the most recent deal valued at ₹ 4.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
